Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.45 CNY -3.37% Market Closed
Market Cap: 98.5B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shanghai RAAS Blood Products Co Ltd

Wall Street analysts forecast Shanghai RAAS Blood Products Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 6.94 CNY with a low forecast of 6.87 CNY and a high forecast of 7.14 CNY.

Lowest
Price Target
6.87 CNY
8% Downside
Average
Price Target
6.94 CNY
7% Downside
Highest
Price Target
7.14 CNY
4% Downside
Shanghai RAAS Blood Products Co Ltd Competitors:
Price Targets
VCEL
Vericel Corp
7% Upside
SIGHT
Gensight Biologics SA
22% Upside
87S
Roivant Sciences Ltd
40% Upside
CPRX
Catalyst Pharmaceuticals Inc
53% Upside
KRRO
Korro Bio Inc
146% Upside
NIOX
Niox Group PLC
29% Upside
ARX
Aroa Biosurgery Ltd
45% Upside
PYXS
Pyxis Oncology Inc
361% Upside

Revenue
Forecast

Revenue Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 10%.

19%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's operating income is 14%. The projected CAGR for the next 3 years is 14%.

14%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 19%.

3%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai RAAS Blood Products Co Ltd's stock price target?
Price Target
6.94 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 6.94 CNY with a low forecast of 6.87 CNY and a high forecast of 7.14 CNY.

What is Shanghai RAAS Blood Products Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 10%.

What is Shanghai RAAS Blood Products Co Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's operating income is 14%. The projected CAGR for the next 3 years is 14%.

What is Shanghai RAAS Blood Products Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 19%.

Back to Top